Stephen Aselage
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stephen Aselage
Stephen Aselage was last confirmed as Board Member at Travere Therapeutics, Inc. (TVTX) in a filing dated April 4, 2022. The proxy statement of Travere Therapeutics, Inc. reports total compensation of $1,039,269 for Stephen Aselage in fiscal 2019, including a base salary of $76,151. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2012-01-01–2022-04-04
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Travere Therapeutics, Inc. (TVTX) | Director and Former President and Chief Executive Officer | $76,151 | $1,039,269 |
| 2018 | Travere Therapeutics, Inc. (TVTX) | Director and Former President and Chief Executive Officer | $593,333 | $4,602,287 |
| 2017 | Travere Therapeutics, Inc. (TVTX) | Director and Former President and Chief Executive Officer | $552,570 | $3,428,325 |
Recent activity
No call appearances or filed executive changes recorded yet.